Toledo, OHNCT03935984Now EnrollingIRB Ready

Primary Hyperparathyroidism Clinical Trial in Toledo, OH

Access cutting-edge primary hyperparathyroidism treatment through this clinical trial at a research site in Toledo. Study-provided care at no cost to qualified participants.

Sponsored by Joseph Sferra

Quick Self-Assessment

See if you qualify for this Toledo location

Preparing your pre-screening questions…

Expert Care in Toledo

Access primary hyperparathyroidism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary hyperparathyroidism treatment provided free

Apply for This Toledo Location

Check if you qualify for this primary hyperparathyroidism clinical trial in Toledo, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Toledo

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Toledo site if eligible
  4. 4Begin participation

About This Primary Hyperparathyroidism Study in Toledo

Patients with biochemically confirmed primary hyperparathyroidism and non-localizing SPECT-CT exam within the past year will be included. Subjects will be treated with calcitonin to lower calcium levels immediately prior to reimaging. The goal of this study is to determine whether lowering calcium will improve uptake/retention of sestamibi and improve sensitivity of SPECT-CT to localize parathyroid adenoma.

Sponsor: Joseph Sferra

Who Can Participate

Inclusion Criteria

Diagnosis of primary hyperparathyroidism
Non-localizing SPECT-CT performed within 365 days prior to consent to participate in study
Patient desires surgical intervention for treatment of PHPT
No contraindications to 99mTC-Sestamibi
No contraindications to treatment with calcitonin
Serum calcium level prior to non-localizing SPECT-CT is ≥10.5 mg/dL
Patient consents to participate and undergo second SPECT-CT for purposes of research

Exclusion Criteria

Previous surgery to the neck, including resection of parathyroid tissue, except where end organ damage is present and further surgical intervention is medically necessary
Contraindication to 99mTC-Sestamibi SPECT-CT as evidenced by allergic reaction or adverse event during index SPECT-CT
Allergy to calcitonin
Hypocalcemia (contraindication to calcitonin)
Vitamin D deficiency (contraindication to calcitonin)
Previous treatment with radioactive iodine
New prescription of thyroid medication (levothyroxine, armour thyroid tablets, etc. must be taken at time of index scan and research scan)
Lithium exposure within one year of SPECT-CT (index and research scans)
Secondary hyperparathyroidism
Benign familial hypocalciuric hypercalcemia
Known malignancy, particularly multiple endocrine neoplasia
New prescription of thiazide diuretic, (thiazide diuretic must have been taken at the time of index scan and second scan)
Currently taking calcium channel blockers

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Toledo?

Yes, this clinical trial (NCT03935984) has an active research site in Toledo, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Hyperparathyroidism Treatment Options in Toledo, OH

If you're searching for primary hyperparathyroidism treatment options in Toledo, OH, this clinical trial (NCT03935984) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Toledo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary hyperparathyroidism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary hyperparathyroidism clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Toledo, OH

See all pulmonary embolism clinical trials recruiting in Toledo — not just this study.

Browse Pulmonary Embolism Trials in Toledo →

Browse More Trials by Condition

Pulmonary Embolism TrialsRheumatoid Arthritis TrialsHyperparathyroidism TrialsRetinitis Pigmentosa TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Toledo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Toledo, OH